Barrs Pharmaceuticals Secures R92m Hetero Investment
Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
Dis-Chem Insurance Branding Non-Compliant says CMS
Dis-Chem health insurance branding issues raise enforcement risk for Centriq’s MyHealth products and potential disruption for policyholders.